<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To study clinical and laboratory characteristics of <z:e sem="disease" ids="C0019158" disease_type="Disease or Syndrome" abbrv="">hepatitides</z:e> and evaluate efficacy of immunosuppressive therapy and transplantation of the bone marrow in <z:hpo ids='HP_0012115'>hepatitis</z:hpo>-associated <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (HAAA) </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIAL AND METHODS: A retrospective analysis of case histories of children with HAAA was made </plain></SENT>
<SENT sid="2" pm="."><plain>For <z:hpo ids='HP_0000001'>all</z:hpo> the patients standard tests for detection of aquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and <z:hpo ids='HP_0012115'>hepatitis</z:hpo> were conducted </plain></SENT>
<SENT sid="3" pm="."><plain>Transplantation of hemopoietic stem cells (THSC) from HLA-identical donors was made in 4 patients, 25 patients were treated with combined immunosuppressive therapy (antithymocytic globulin--ATG plus <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> -CsA), one patients received monotherapy with CsA, two--<z:chebi fb="2" ids="8378">prednisolone</z:chebi> and a short course of CsA, one child was untreated </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Of 260 children admitted to hospital from April 1989 to July 2005 for aquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, 33 (12.7%) met diagnostic criteria of HAAA </plain></SENT>
<SENT sid="5" pm="."><plain>Boys to girls ratio was 267 </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0019158" disease_type="Disease or Syndrome" abbrv="">Hepatitides</z:e> were severe: median of alaninaminotransferase concentration was 1215 IU/l, aspartataminotransferase--789 IU/l, <z:chebi fb="0" ids="16990">bilirubin</z:chebi>--152.5 mcmol/l </plain></SENT>
<SENT sid="7" pm="."><plain>Median of the interval from <z:hpo ids='HP_0012115'>hepatitis</z:hpo> symptoms to documentation of <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> was 66 days (0-204 days) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> four patients after THSC are alive for 30-72 months </plain></SENT>
<SENT sid="9" pm="."><plain>Probability of complete remission after the first course of ATG+CsA is 0.72 +/- 0.09, probability of survival 0.81 +/- 0.07, median of the interval to transfusion independence--50 days </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: HAAA prognosis is good only in administration of up-to-date therapy </plain></SENT>
<SENT sid="11" pm="."><plain>After seronegative <z:hpo ids='HP_0012115'>hepatitis</z:hpo> it is necessary to control hemogram parameters and in the presence of minimal cytopenia patients should be directed to hematological hospital </plain></SENT>
</text></document>